Chugai Pharmaceutical Co Ltd - Company Profile
Powered by 
All the data and insights you need on Chugai Pharmaceutical Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Chugai Pharmaceutical Co Ltd Strategy Report
- Understand Chugai Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Chugai Pharmaceutical Co Ltd (Chugai), a subsidiary of F. Hoffmann-La Roche Ltd, manufactures, markets, exports and imports pharmaceutical products in Japan and other countries. It provides drugs for cancer; renal diseases; bone and joint diseases, transplant, immunology and infectious diseases and others therapy areas.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
The company’s R&D activities focus on developing novel pharmaceuticals to address unmet medical needs and benefit human health and the medical community worldwide. The company has several products in various stages of development in cancer, bone and joint diseases, renal diseases, autoimmune diseases, neurology and other areas. In FY2022, it spent JPY148,061 million on R&D activities, which grew 12.8% YoY and accounted for 11.8% of the annual revenue. The company operates three research laboratories in Gotemba and Kamakura. It also focuses on antibody drug, cellular and gene therapy product. Chugai harnesses its proprietary technology and global network to produce new drugs from its own research.
Business Segments
Overview
Consists of the R&D of innovative prescription medicines and the subsequent manufacturing, marketing and distribution activities. Pharmaceuticals segment is classified into four product categories: Oncology; Bone and Joint Diseases/ Autoimmune Diseases (BJD/AD); Renal Diseases; and Others. Major Oncology Products include Avastin (for various types of cancer), Tecentriq, Herceptin, Perjeta, Neutrogin and Kadcyla (HER2-positive metastatic breast cancer), Rituxan (CD20-positive B-cell non-Hodgkin’s lymphoma), Alecensa (ALK positive, metastatic NSCLC), Xeloda (advanced recurrent colorectal cancer, breast and gastric cancer), Tarceva (second-line treatment of NSCLC) and Neutrogen (neutropenia); BJD/AD products include Actemra, Edirol and Bonviva (osteoporosis) Suvenyl (rheumatoid arthritis); renal disease products include Mircera (renal anemia) and Oxarol (secondary hyperparathyroidism); and others include Tamiflu (anti-influenza agent) and CellCept (refractory rejection after kidney heart, liver, lung and pancreas transplants).
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Geographical Segments
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward